Spring 2024
Bioprocessing & Precision Fermentation
The biotech and pharma branch is growing steadily. Many companies have full order books for the next few years and expect growth. This is the basis for new investments in assets and infrastructure. These growing structures often expose vulnerabilities and challenges for the business. Therefore, companies need to increase the stability and efficiency of their processes.
Money for new bioprocesses
Whether therapeutics, novel food or sustainable bioproduction: the UK is leading the way with a £2bn bioengineering initiative over ten years that in its first draft was 90% biomedical, but has been revised after the US bioeconomy strategy came out.
A novel BPM system
The biotech and pharma branch is growing steadily. Many companies have full order books for the next few years and expect growth. This is the basis for new investments in assets and infrastructure. These growing structures often expose vulnerabilities and challenges for the business. Therefore, companies need to increase the stability and efficiency of their processes.
Experts in microbial technology
The world of microbial product manufacturing is a complex landscape, driven by a diverse range of molecule formats and manufacturing processes. At the forefront of this specialty market is Boehringer Ingelheim Vienna, one global leader in biopharmaceutical development and manufacturing.
How CDMOs become strong partners
Professionalism and quality are always at the forefront along the whole value chain: from gene to product. To pro-actively meet the evolving demand of the market to produce new assets Richter-Helm significantly increased its manufacturing capacities for biopharmaceutical products at its production site in Bovenau, Germany.
GMP PharmaCongress 2024
Pandemic preparedness, new vaccines and gene therapies – together with the classic aseptic manufacturing topics the PharmaCongress 2024 offers a comprehensive programme.
